Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer

Christine Heisterkamp, Tiina Haatanen, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background and Purpose: Whole-brain radiotherapy (WBRT) alone is the most common treatment for brain metastases from colorectal cancer, as most patients are not candidates for more aggressive therapies such as resection or radiosurgery. The standard WBRT regimen, 30 Gy in ten fractions (10 × 3 Gy), has generally resulted in poor outcomes. This study investigated whether an escalation of the WBRT dose improves these results. Patients and Methods: Data from 53 patients receiving WBRT alone for brain metastases from colorectal cancer were retrospectively analyzed. 10 × 3 Gy (n = 35) was compared to higher doses (40 Gy/20 fractions or 45 Gy/15 fractions; n = 18) for overall survival (OS) and local control (LC). Additional factors evaluated for prognostic importance included age, gender, performance status, number of metastases, and extracerebral metastases. Results: The OS rates at 6 months were 17% after 10 × 3 Gy and 50% after 20 × 2 Gy/15 × 3 Gy (p = 0.014). On multivariate analysis, improved OS was significantly associated with higher WBRT dose (p = 0.047), Karnofsky Performance Score (KPS) ≥ 70 (p = 0.034), less than four brain metastases (p = 0.036), and lack of extracerebral metastases (p = 0.010). The LC rates at 6 months were 17% after 10 × 3 Gy and 50% after higher doses (p = 0.018). On multivariate analysis of LC, higher WBRT dose was significant (p = 0.028). A trend was observed for KPS ≥ 70 (p = 0.08) and less than four brain metastases (p = 0.06). Conclusion: These data suggest that patients with brain metastases from colorectal cancer treated with WBRT alone appeared to benefit from escalation of the radiation dose beyond 10 × 3 Gy in terms of improved OS and LC.

Original languageEnglish (US)
Pages (from-to)70-75
Number of pages6
JournalStrahlentherapie und Onkologie
Volume186
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Colorectal Neoplasms
Radiotherapy
Neoplasm Metastasis
Brain
Survival
Multivariate Analysis
Radiosurgery
Survival Rate
Radiation
Therapeutics

Keywords

  • Brain metastases
  • Colorectal cancer
  • Dose escalation
  • Local control
  • Overall survival

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Oncology
  • Medicine(all)

Cite this

Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer. / Heisterkamp, Christine; Haatanen, Tiina; Schild, Steven E.; Rades, Dirk.

In: Strahlentherapie und Onkologie, Vol. 186, No. 2, 02.2010, p. 70-75.

Research output: Contribution to journalArticle

Heisterkamp, Christine ; Haatanen, Tiina ; Schild, Steven E. ; Rades, Dirk. / Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer. In: Strahlentherapie und Onkologie. 2010 ; Vol. 186, No. 2. pp. 70-75.
@article{f3f934e7b5c041169597f509a55980c7,
title = "Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer",
abstract = "Background and Purpose: Whole-brain radiotherapy (WBRT) alone is the most common treatment for brain metastases from colorectal cancer, as most patients are not candidates for more aggressive therapies such as resection or radiosurgery. The standard WBRT regimen, 30 Gy in ten fractions (10 × 3 Gy), has generally resulted in poor outcomes. This study investigated whether an escalation of the WBRT dose improves these results. Patients and Methods: Data from 53 patients receiving WBRT alone for brain metastases from colorectal cancer were retrospectively analyzed. 10 × 3 Gy (n = 35) was compared to higher doses (40 Gy/20 fractions or 45 Gy/15 fractions; n = 18) for overall survival (OS) and local control (LC). Additional factors evaluated for prognostic importance included age, gender, performance status, number of metastases, and extracerebral metastases. Results: The OS rates at 6 months were 17{\%} after 10 × 3 Gy and 50{\%} after 20 × 2 Gy/15 × 3 Gy (p = 0.014). On multivariate analysis, improved OS was significantly associated with higher WBRT dose (p = 0.047), Karnofsky Performance Score (KPS) ≥ 70 (p = 0.034), less than four brain metastases (p = 0.036), and lack of extracerebral metastases (p = 0.010). The LC rates at 6 months were 17{\%} after 10 × 3 Gy and 50{\%} after higher doses (p = 0.018). On multivariate analysis of LC, higher WBRT dose was significant (p = 0.028). A trend was observed for KPS ≥ 70 (p = 0.08) and less than four brain metastases (p = 0.06). Conclusion: These data suggest that patients with brain metastases from colorectal cancer treated with WBRT alone appeared to benefit from escalation of the radiation dose beyond 10 × 3 Gy in terms of improved OS and LC.",
keywords = "Brain metastases, Colorectal cancer, Dose escalation, Local control, Overall survival",
author = "Christine Heisterkamp and Tiina Haatanen and Schild, {Steven E.} and Dirk Rades",
year = "2010",
month = "2",
doi = "10.1007/s00066-010-2067-8",
language = "English (US)",
volume = "186",
pages = "70--75",
journal = "Strahlentherapie und Onkologie : Organ der Deutschen R{\"o}ntgengesellschaft ... [et al]",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "2",

}

TY - JOUR

T1 - Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer

AU - Heisterkamp, Christine

AU - Haatanen, Tiina

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2010/2

Y1 - 2010/2

N2 - Background and Purpose: Whole-brain radiotherapy (WBRT) alone is the most common treatment for brain metastases from colorectal cancer, as most patients are not candidates for more aggressive therapies such as resection or radiosurgery. The standard WBRT regimen, 30 Gy in ten fractions (10 × 3 Gy), has generally resulted in poor outcomes. This study investigated whether an escalation of the WBRT dose improves these results. Patients and Methods: Data from 53 patients receiving WBRT alone for brain metastases from colorectal cancer were retrospectively analyzed. 10 × 3 Gy (n = 35) was compared to higher doses (40 Gy/20 fractions or 45 Gy/15 fractions; n = 18) for overall survival (OS) and local control (LC). Additional factors evaluated for prognostic importance included age, gender, performance status, number of metastases, and extracerebral metastases. Results: The OS rates at 6 months were 17% after 10 × 3 Gy and 50% after 20 × 2 Gy/15 × 3 Gy (p = 0.014). On multivariate analysis, improved OS was significantly associated with higher WBRT dose (p = 0.047), Karnofsky Performance Score (KPS) ≥ 70 (p = 0.034), less than four brain metastases (p = 0.036), and lack of extracerebral metastases (p = 0.010). The LC rates at 6 months were 17% after 10 × 3 Gy and 50% after higher doses (p = 0.018). On multivariate analysis of LC, higher WBRT dose was significant (p = 0.028). A trend was observed for KPS ≥ 70 (p = 0.08) and less than four brain metastases (p = 0.06). Conclusion: These data suggest that patients with brain metastases from colorectal cancer treated with WBRT alone appeared to benefit from escalation of the radiation dose beyond 10 × 3 Gy in terms of improved OS and LC.

AB - Background and Purpose: Whole-brain radiotherapy (WBRT) alone is the most common treatment for brain metastases from colorectal cancer, as most patients are not candidates for more aggressive therapies such as resection or radiosurgery. The standard WBRT regimen, 30 Gy in ten fractions (10 × 3 Gy), has generally resulted in poor outcomes. This study investigated whether an escalation of the WBRT dose improves these results. Patients and Methods: Data from 53 patients receiving WBRT alone for brain metastases from colorectal cancer were retrospectively analyzed. 10 × 3 Gy (n = 35) was compared to higher doses (40 Gy/20 fractions or 45 Gy/15 fractions; n = 18) for overall survival (OS) and local control (LC). Additional factors evaluated for prognostic importance included age, gender, performance status, number of metastases, and extracerebral metastases. Results: The OS rates at 6 months were 17% after 10 × 3 Gy and 50% after 20 × 2 Gy/15 × 3 Gy (p = 0.014). On multivariate analysis, improved OS was significantly associated with higher WBRT dose (p = 0.047), Karnofsky Performance Score (KPS) ≥ 70 (p = 0.034), less than four brain metastases (p = 0.036), and lack of extracerebral metastases (p = 0.010). The LC rates at 6 months were 17% after 10 × 3 Gy and 50% after higher doses (p = 0.018). On multivariate analysis of LC, higher WBRT dose was significant (p = 0.028). A trend was observed for KPS ≥ 70 (p = 0.08) and less than four brain metastases (p = 0.06). Conclusion: These data suggest that patients with brain metastases from colorectal cancer treated with WBRT alone appeared to benefit from escalation of the radiation dose beyond 10 × 3 Gy in terms of improved OS and LC.

KW - Brain metastases

KW - Colorectal cancer

KW - Dose escalation

KW - Local control

KW - Overall survival

UR - http://www.scopus.com/inward/record.url?scp=77449100497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449100497&partnerID=8YFLogxK

U2 - 10.1007/s00066-010-2067-8

DO - 10.1007/s00066-010-2067-8

M3 - Article

C2 - 20127223

AN - SCOPUS:77449100497

VL - 186

SP - 70

EP - 75

JO - Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

JF - Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

SN - 0179-7158

IS - 2

ER -